首页> 外文学位 >Amphiphilic macromolecule-lipid complexes as drug delivery systems: Physical and biological characterization.
【24h】

Amphiphilic macromolecule-lipid complexes as drug delivery systems: Physical and biological characterization.

机译:两亲高分子-脂质复合物作为药物输送系统:物理和生物学特性。

获取原文
获取原文并翻译 | 示例

摘要

Cancer is the second most common death in the US accounting for 25% of all deaths. Many of the potent anti-cancer drugs are insoluble in water and require drug delivery agents. However, many of these agents are therapeutically inefficient and are associated with adverse side effects. Amphiphilic Macromolecules (AM) are a novel class of micelle forming materials with drug delivery applications. A screening of amphiphilic macromolecules against primary human cells of the vasculature in vitro showed good biocompatibility. To further their drug delivery potential, AMs were physically complexed with liposomes composed of a 1:1 mix of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) for form AM-lipid complexes . Altering the AM-lipid method of assembly (co-evaporation (CE) or post-addition (PA)), as well as the AM to lipid ratios, allows the complexes to exist as either lamellar aggregates, micellar aggregates, or as AM-coated liposomes. AM-lipid complexes exhibit tunable zeta potential, steric stability, and inherently low cytotoxicity. Significantly, AM-lipid complexes exhibit a preferential uptake in carcinoma cells over normal cells in vitro demonstrating a unique, passive targeting approach to delivery anti-cancer therapeutics. AM-lipid complexes were loaded with the hydrophobic anti-cancer drug paclitaxel (PTX). The loading of PTX does not significantly affect the size of the nanocarriers. Paclitaxel-loaded 1:1 AM-lipid complexes showed drug-mediated, dose-dependent cytotoxicity towards BT-20 cell in vitro. Over thirty days, Balb/C mice systemically treated with PTX-loaded AM-lipid complexes showed higher in vivo tolerability than Taxol-treated mice. Studies investigating the thermodynamic and physical interactions between AMs and DOPE:DOTAP liposomes showed a cooperative intermolecular interactions between pure lipids and AM in monolayers and high affinity of AM micelles for DOTAP: DOPE liposomes in buffer solution respectively. Increasing the complex's AM weight ratio in the CE method led to the complete solubilization of the vesicles from lamellar aggregates, to a mixture of co-existing vesicles and micelles, to mixed micelles. At higher AM weight ratios, PA-produced complexes exhibit greater stability than complexes at lower AM weight ratio and complexes produced by the CE methods showed stronger interactions between AM-lipid components than complexes produced by the PA method. The results suggest that the PA method produces vesicles with AM molecules associated with its outer leaflet only (i.e., an AM-coated vesicle), while the CE method produces complexes ranging from mixed vesicles to mixed micelle in which the AM-lipid components are more intimately associated. Based on these results, AM-lipid complexes show promise as a novel nanocarriers for paclitaxel delivery.
机译:癌症是美国第二大常见死亡,占所有死亡的25%。许多有效的抗癌药不溶于水,需要药物递送剂。然而,这些试剂中的许多在治疗上效率低下并且与不良副作用有关。两亲高分子(AM)是一类新型的胶束形成材料,具有药物输送应用。体外针对血管的原代人类细胞的两亲大分子筛选显示出良好的生物相容性。为了进一步提高其给药潜力,将AMs与脂质体进行物理复合,脂质体由1,1,2-油酰基-sn-甘油-3-磷酸乙醇胺(DOPE)和1,2-二油酰基--3-三甲基铵-丙烷( DOTAP)用于形成AM-脂质复合物。改变AM-脂质的组装方法(共蒸发(CE)或添加后(PA))以及AM与脂质的比率,可以使复合物以层状聚集体,胶束聚集体或AM-包衣脂质体。 AM-脂质复合物显示出可调的ζ电位,空间稳定性和固有的低细胞毒性。重要的是,AM-脂质复合物在体外的癌细胞中比正常细胞表现出优先的摄取,这证明了独特的被动靶向方法可用于递送抗癌治疗剂。 AM-脂质复合物载有疏水性抗癌药紫杉醇(PTX)。 PTX的负载不会显着影响纳米载体的尺寸。紫杉醇负载的1:1 AM-脂质复合物在体外对BT-20细胞表现出药物介导的剂量依赖性细胞毒性。在30天以上的时间里,用PTX加载的AM-脂质复合物系统治疗的Balb / C小鼠的体内耐受性比紫杉醇治疗的小鼠高。研究AM与DOPE:DOTAP脂质体之间的热力学和物理相互作用的研究表明,单层纯脂质与AM之间存在协同的分子间相互作用,并且AM胶束分别对缓冲液中的DOTAP:DOPE脂质体具有高亲和力。在CE方法中增加复合物的AM重量比可导致囊泡从层状聚集体到共存囊泡和胶束的混合物到混合胶束的完全溶解。在较高的AM重量比下,PA生成的复合物比在较低的AM重量比下的复合物表现出更大的稳定性,通过CE方法生成的复合物显示出比通过PA方法生成的复合物更强的AM-脂质成分之间的相互作用。结果表明,PA方法产生的囊泡中仅带有与其外部小叶相关的AM分子(即AM包被的囊泡),而CE方法产生的复合物范围从混合囊泡到混合胶束,其中AM-脂质成分更多紧密联系。基于这些结果,AM-脂质复合物显示出作为紫杉醇递送的新型纳米载体的希望。

著录项

  • 作者

    Harmon, Alexander M.;

  • 作者单位

    Rutgers The State University of New Jersey - New Brunswick.;

  • 授予单位 Rutgers The State University of New Jersey - New Brunswick.;
  • 学科 Chemistry Biochemistry.;Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2011
  • 页码 147 p.
  • 总页数 147
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号